维普中文期刊产品整合服务
10篇 您的检索式:作者名="Pan Yile"
    题名 作者 年代 出处 被引量
1Enhancement of oral bioavailability and anti-Parkinsonian efficacy of resveratrol through a nanocrystal formulation显示文摘Resveratrol(RES),a non-flavonoid polyphenol extracted from a wide variety of plants,exhibits neuroprotective activities against Parkinson’s disease(PD).However,undesirable water solubility of RES reduces its oral bioavailability and demonstrates lowefficacy in blood and brain,thus limiting its application.In present study,a nanocrystal formulation of RES(RES-NCs)was developed to enhance its oral bioavailability and delivery into brain for PD treatment.RES-NCs were fabricated with hydroxypropyl methylcellulose(HPMC)stabilizer via antisolvent precipitation approach.The obtained RES-NCs displayed the particle size of 222.54±1.66 nm,the PDI of 0.125±0.035,the zeta potential of−9.41±0.37mV,and a rapid in vitro dissolution rate.Molecular dynamics simulation of RES and HPMC revealed an interaction energy of−68.09 kJ/mol and a binding energy of−30.98±0.388 kJ/mol,indicating that the spontaneous binding between the two molecules is through van der Waals forces.RES-NCs conferred enhanced cellular uptake as well as improved permeability relative to pure RES.In addition,RES-NCs were able to protect neurons against cytotoxicity induced by MPP+.Meanwhile,RES-NCs exerted no significant toxic effects on zebrafish embryos and larvae,and did not influence their survival and hatching rates.When orally administered to rats,RES-NCs exhibited more favorable pharmacokinetics than pure RES,with higher plasma and brain concentrations.More importantly,MPTP-induced PD mice showed notable improvements in behavior,attenuated dopamine deficiency,and elevated levels of dopamine and its metabolites after the treatment with RES-NCs.Furthermore,immunoblot analysis revealed that the neuroprotective role of RES-NCsmay be at least partially mediated by Akt/Gsk3βsignaling pathway.Taken altogether,RES-NCs can serve as a potential treatment modality for PD,offering means of improving RES oral bioavailability and brain accumulation.Sha Xiong Wei Liu Yile Zhou Yousheng Mo Yao Liu Xiaojia Chen Huafeng Pan Dongsheng Yuan QiWang Tongkai Chen 2020Asian Journal of Pharmaceutical Sciences2020,15,4:3
2A Convenient and Biosafe Replicon with Accessory Genes of SARS-CoV-2 and Its Potential Application in Antiviral Drug Discovery显示文摘SARS-CoV-2 causes the pandemic of COVID-19 and no effective drugs for this disease are available thus far.Due to the high infectivity and pathogenicity of this virus,all studies on the live virus are strictly confined in the biosafety level 3(BSL3)laboratory but this would hinder the basic research and antiviral drug development of SARS-CoV-2 because the BSL3 facility is not commonly available and the work in the containment is costly and laborious.In this study,we constructed a reverse genetics system of SARS-CoV-2 by assembling the viral cDNA in a bacterial artificial chromosome(BAC)vector with deletion of the spike(S)gene.Transfection of the cDNA into cells results in the production of an RNA replicon that keeps the capability of genome or subgenome replication but is deficient in virion assembly and infection due to the absence of S protein.Therefore,such a replicon system is not infectious and can be used in ordinary biological laboratories.We confirmed the efficient replication of the replicon by demonstrating the expression of the subgenomic RNAs which have similar profiles to the wild-type virus.By mutational analysis of nsp12 and nsp14,we showed that the RNA polymerase,exonuclease,and cap N7 methyltransferase play essential roles in genome replication and sgRNA production.We also created a SARS-CoV-2 replicon carrying a luciferase reporter gene and this system was validated by the inhibition assays with known anti-SARS-CoV-2 inhibitors.Thus,such a one-plasmid system is biosafe and convenient to use,which will benefit both fundamental research and development of antiviral drugs.Yun-Yun Jin Hanwen Lin Liu Cao Wei-Chen Wu Yanxi Ji Liubing Du Yiling Jiang Yanchun Xie Kuijie Tong Fan Xing Fuxiang Zheng Mang Shi Ji-An Pan Xiaoxue Peng Deyin Guo 2021Virologica Sinica2021,36,5:2
3Phylogeny of the genus Morus (Urticales:Moraceae) inferred from ITS and trnL-F sequences,African显示文摘Zhao Weiguo Pan Yile Zhang Zhifang 2005Journal of Biotechnology2005,4,6:1
4A comparison of genetic variation among wild and cultivated Morus species (Moraceae:Morus) as revealed by ISSR and SSR markers显示文摘Zhao Weiguo Miao Xuxiaa Pan Yile 2007Biodiversity and Conversation2007,16,2:1
5J-Beauty Tops K-Beauty in China显示文摘Nowadays,Chinese beauty market is experiencing a great competition between Korean(K-Beauty)and Japanese(J-Beauty)products.Though some Korean beauty products like cushion compacts and CC cream are still in hot demand in China, Japanese beauty (J-Beauty)have recently begun to offer some fierce competition.Accordingto l2 NewYorkresearchgroup。Pan Yiling 2018China Detergent & Cosmetics2018,3,2:0
6Reflections on Energy Planning of Beijing显示文摘Urban energy planning is aimed at formulating an urban energy development strategy in order to ensure adequate and stable energy supply, to optimize the energy supply structure, to set the goal of energy development, and to promote energy-efficient technology, so as to build up an energy supply and demand system,which will be win-win in terms of socioeconomic effects and environ-ecological effects. Therefore, energyPAN Yiling, Beijing Municipal Institute of City Planning & Design, Beijing, P. R. ChinaXU Yanfeng, Beijing Municipal Institute of City Planning & Design, Beijing, P. R. China 2006China City Planning Review2006,15,1:0
7Status Quo of Maker Spaces in Main Urban Area of Chengdu显示文摘This paper, based on the literature review and field investigation, studied the status quo of maker spaces in main urban district of Chengdu at a time when the development of the maker spaces has received strong support from national and local governments. In addition to introducing the related concepts and policy support of the maker space, it summarized its distribution characteristics, audience characteristics, and status quo as well as problems and presented the direction for the development of the maker space in main urban area of Chengdu grounded on a survey of the status quo of national maker spaces in main urban area of Chengdu.GAO Wei LIU Pan LIANG Zihan HOU Junzheng LUO Tianze LU Baorong WANG Xufei YU Xinyu FENG Yajin REN Zijie DU Jinqiang BAI Yile WANG Kejie SUN Zhentong 2017Journal of Landscape Research2017,9,4:0
8In-situ growth of low-dimensional perovskite-based insular nanocrystals for highly efficient light emitting diodes显示文摘Regulation of perovskite growth plays a critical role in the development of high-performance optoelectronic devices.However,judicious control of the grain growth for perovskite light emitting diodes is elusive due to its multiple requirements in terms of morphology,composition,and defect.Herein,we demonstrate a supramolecular dynamic coordination strategy to regulate perovskite crystallization.The combined use of crown ether and sodium trifluoroacetate can coordinate with A site and B site cations in ABX_(3) perovskite,respectively.The formation of supramolecular structure retard perovskite nucleation,while the transformation of supramolecular intermediate structure enables the release of components for slow perovskite growth.This judicious control enables a segmented growth,inducing the growth of insular nanocrystal consist of low-dimensional structure.Light emitting diode based on this perovskite film eventually brings a peak external quantum efficiency up to 23.9%,ranking among the highest efficiency achieved.The homogeneous nano-island structure also enables high-efficiency large area(1 cm^(2))device up to 21.6%,and a record high value of 13.6%for highly semi-transparent ones.Hao Wang Weidong Xu Qi Wei Si Peng Yuequn Shang Xianyuan Jiang Danni Yu Kai Wang Ruihua Pu Chenxi Zhao Zihao Zang Hansheng Li Yile Zhang Ting Pan Zijian Peng Xiaoqin Shen Shengjie Ling Weimin Liu Feng Gao Zhijun Ning 2023Light(Science & Applications)2023,12,3:0
9Adjuvant chemotherapy versus adjuvant concurrent chemoradiotherapy after radical surgery for early-stage cervical cancer:a randomized,non-inferiority,multicenter trial显示文摘We conducted a prospective study to assess the non-inferiority of adjuvant chemotherapy alone versus adjuvant concurrent chemoradiotherapy (CCRT) as an alternative strategy for patients with early-stage (FIGO 2009 stage IB–IIA) cervical cancer having risk factors after surgery. The condition was assessed in terms of prognosis, adverse effects, and quality of life. This randomized trial involved nine centers across China. Eligible patients were randomized to receive adjuvant chemotherapy or CCRT after surgery. The primary end-point was progression-free survival (PFS). From December 2012 to December 2014, 337 patients were subjected to randomization. Final analysis included 329 patients, including 165 in the adjuvant chemotherapy group and 164 in the adjuvant CCRT group. The median follow-up was 72.1 months. The three-year PFS rates were both 91.9%, and the five-year OS was 90.6% versus 90.0% in adjuvant chemotherapy and CCRT groups, respectively. No significant differences were observed in the PFS or OS between groups. The adjusted HR for PFS was 0.854 (95% confidence interval 0.415–1.757;P = 0.667) favoring adjuvant chemotherapy, excluding the predefined non-inferiority boundary of 1.9. The chemotherapy group showed a tendency toward good quality of life. In comparison with post-operative adjuvant CCRT, adjuvant chemotherapy treatment showed non-inferior efficacy in patients with early-stage cervical cancer having pathological risk factors. Adjuvant chemotherapy alone is a favorable alternative post-operative treatment.Danhui Weng Huihua Xiong Changkun Zhu Xiaoyun Wan Yaxia Chen Xinyu Wang Youzhong Zhang Jie Jiang Xi Zhang Qinglei Gao Gang Chen Hui Xing Changyu Wang Kezhen Li Yaheng Chen Yuyan Mao Dongxiao Hu Zimin Pan Qingqin Chen Baoxia Cui Kun Song Cunjian Yi Guangcai Peng Xiaobing Han Ruifang An Liangsheng Fan Wei Wang Tingchuan Xiong Yile Chen Zhenzi Tang Lin Li Xingsheng Yang Xiaodong Cheng Weiguo Lu Hui Wang Beihua Kong Xing Xie Ding Ma 2023Frontiers of Medicine2023,17,1:0
10Enhanced energy-storage performance in BNT-based lead-free dielectric ceramics via introducing SrTi_(0.875)Nb_(0.1)O_(3)显示文摘Environmentally friendly lead-free ceramics capacitors,with outstanding power density,rapid charging/discharging rate,and superior stability,have been receiving increasing attention of late for their ability to meet the critical requirements of pulsed power devices in low-consumption systems.However,the relatively low energy storage capability must be urgently overcome.Herein,this work reports on leadfree SrTi_(0.875)Nb_(0.1)O_(3)(STN)replacement of(Bi_(0.47)La_(0.03)Na_(0.5))_(0.94)Ba_(0.06)TiO_(3)(BLNBT)ferroelectric ceramics with excellent energy storage performance.Improving relaxor behaviour and breakdown strength(Eb),decreasing grain size,and mitigating large polarization difference are conductive to the enhancement of comprehensive energy storage performances.The phase-field simulation methods are further analysized evolution process of electrical tree in the experimental breakdown.In particular,the 0.70BLNBT-0.30STN ceramic exhibit a large discharged energy density of 4.2 J/cm^(3) with an efficiency of 89.3%at room temperature under electric field of 380 kV/cm.Additionally,for practical applications,the BLNBT-based ceramics achieve a high power density(~62.3 MW/cm^(3))and fast discharged time(~148.8 ns)over broad temperature range(20-200℃).Therefore,this work can provide a simple and effective guideline paradigm for acquiring high-performance dielectric materials in low-consumption systems operating in a wide range of temperatures and long-term operations.Lukang Wu Luomen Tang Yizan Zhai Yiling Zhang Jianjian Sun Di Hu Zhongbin Pan Zhen Su Yang Zhang Jinjun Liu 2022Journal of Materiomics2022,8,3:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费